Ali Zarrinpar, MD, Brian Ramnaraign, MD, Steven Hughes, MD, and Kathryn Hitchcock, MD, discuss neuroendocrine tumor (NET) management – the state of the art in 2021, including PRRT.
They give an overview of the current management of neuroendocrine tumors. They describe the use of peptide receptor radionuclide therapy for treatment for NETs and they explain when, in the course of the disease, PRRT is best given

Michael Okun, MD, and Kelly Foote, MD, offer an update on DBS and Parkinson’s. They share the UF Research Study: Home-management of DBS settings and their recent clinical trial which is focused on patients being able to have their device systems at home, not in the clinic, which makes this treatment far more accessible to people who have difficulty traveling.

Kevin Campbell, MD, discusses hypogonadism and the management of testosterone therapy. He shares the essential of recognizing hypogonadism and describes the evaluation and diagnostic criteria. He offers guidance in the management, risks, and benefits of testosterone therapy.

Padraic O’Malley, MSc, MD, FRCSC, discusses advanced kidney cancer management at UF Health Shands Hospital. He shares how they utilize surgery, radiation, and medical oncology therapies, some of the most exciting advanced surgical technologies, and how the utilization of a multidisciplinary team been ideal for managing these complex patients.

Zeina Al-Mansour, MD, discusses advances in malignant hematology. She shares the role of precision medicine and molecular-targeted therapy in malignant hematology practice. She examines the role of immune-oncology in the treatment of blood malignancies and walks us through novel immune-based therapeutics: BiTEs, Checkpoint inhibitors, and CAR-T cell therapy.

Wai Lang Lau, MD. discusses the histology and pathological scoring of IgA glomerulonephritis. She helps us to understand the genetics and pathophysiology as well as the heterogeneity of phenotype and she explains the latest treatment options – present and future.

Paul Crispen, MD, defines recurrence rates in stage I bladder cancer. He characterizes established methods to decrease disease recurrence and helps us to recognize barriers to implementing methods that would improve outcomes.

Zeina Al-Mansour, MD, discusses the unique aspects of cancer care in elderly patients. She shares the latest information on anti-tumor immunity & aging, the importance of assessment of functional status and quality of life consideration and the emerging role comprehensive geriatric assessment in oncology practice.

Robin Petroze, MD, and Erin Murray, APRN, discuss the role of bowel management programs in pediatric patients with colorectal conditions. They help us to understand the role of a bowel management program in pediatric colorectal conditions. They offer specific approaches to bowel management in patients with anorectal malformations and Hirschsprung disease and they explore surgical options available for pediatric patients with longstanding bowel management needs.